ErkrankungPränatale Lissenzephalie
Zusammenfassung
Umfassendes differentialdiagnostisches panel für Pränatale Lissenzephalie mit 20 bzw. zusammen genommen 28 kuratierten Genen gemäß klinischer Verdachtsdiagnose
73,7 kb (Erweitertes Panel)
- Chorionzotten (CVS)
- Fruchtwasser (nach AC)
- Nabelschnurblut (NB)
NGS +
Genpanel
Ausgewählte Gene
Name | Exon-Länge (bp) | OMIM-G | Erbgang |
---|---|---|---|
ACTB | 1128 | AD | |
ACTG1 | 1128 | AD | |
B3GALNT2 | 1503 | AR | |
DCX | 1083 | XL | |
FKRP | 1488 | AR | |
FKTN | 1386 | AR | |
KATNB1 | 1968 | AR | |
LAMB1 | 5361 | AR | |
MACF1 | 16293 | AD | |
NDE1 | 1008 | AR | |
PAFAH1B1 | 1233 | AD | |
POMGNT1 | 1983 | AR | |
POMGNT2 | 1743 | AR | |
POMT1 | 2244 | AR | |
POMT2 | 2253 | AR | |
RELN | 10383 | AD und/oder AR | |
TMTC3 | 2745 | AR | |
TUBA1A | 1356 | AD | |
WDR62 | 4572 | AR | |
ATP6V0A2 | 2571 | AR | |
B4GAT1 | 1248 | AR | |
CDK5 | 783 | AR | |
CEP85L | 2418 | AD | |
CRADD | 600 | AR | |
CRPPA | 1356 | AR | |
GMPPB | 1164 | AR | |
VLDLR | 2622 | AR |
Infos zur Erkrankung
Gesamtoberfläche/Teile des Gehirns erscheinen glatt, ohne Falten Gyri + Sulci. Verdacht kann nach >24 Schwangerschaftswochen erhoben werden. Parieto-okzipitale + sylvische Fissuren erscheinen flach, der Subarachnoidalraum ist in der Regel vergrössert. In allen Fällen von scheinbar isolierten Hirnanomalien sollte eine detaillierte Nachbeobachtung nach ~26 Wochen Lissenzephalie ausschließen. Typ I: Agyrie mit fehlender neuronaler Migration; Kortex ist glatt, dick; Typ II: ausgedehnte, ungeordnete Migration mit fehlender Schichtung; Kortex wird als Kopfsteinpflaster beschrieben.
- Allelic: Cardiomyopathy, dilated, 1X (FKTP)
- Allelic: Cutis laxa, autosomal recessive, type IIA (ATP6V0A2)
- Allelic: Deafness, AD 20/26 (ACTG1)
- Allelic: Dystonia, juvenile-onset (ACTB)
- Allelic: Epilepsy, familial temporal lobe, 7 (RELN)
- Allelic: Hydranencephaly with abnormal genitalia (ARX)
- Allelic: Mental retardation, XL 29 + others (ARX)
- Allelic: Microhydranencephaly (NDE1)
- Allelic: Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1 (POMT1)
- Allelic: Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14 (GMPPB)
- Allelic: Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2 (POMT2)
- Allelic: Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3 (POMGNT1)
- Allelic: Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4 (FKTP)
- Allelic: Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5 (FKRP)
- Allelic: Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7 (CRPPA)
- Allelic: Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 8 (POMGNT2)
- Allelic: Partington syndrome (ARX)
- Allelic: Retinitis pigmentosa 76 (POMGNT1)
- Allelic: Wrinkly skin syndrome (ATP6V0A2)
- Baraitser-Winter syndrome 1 (ACTB)
- Baraitser-Winter syndrome 2 (ACTG1)
- Cerebellar hypoplasia + mental retardation with/-out quadrupedal locomotion 1 (VLDLR)
- Epileptic encephalopathy, early infantile, 1 (ARX)
- Intellectual developmental disorder, AR 75, neuropsych. features + variant lissencephaly (PIDD1)
- Lissencephaly 1 (PAFAH1B1)
- Lissencephaly 10 (CEP85L)
- Lissencephaly 2 (Norman-Roberts type (RELN)
- Lissencephaly 3 (TUBA1A)
- Lissencephaly 4 [with microcephaly] (NDE1)
- Lissencephaly 5 (LAMB1)
- Lissencephaly 6, with microcephaly (KATNB1)
- Lissencephaly 7 with cerebellar hypoplasia (CDK5)
- Lissencephaly 8 (TMTC3)
- Lissencephaly 9 with complex brainstem malformation (MACF1)
- Lissencephaly, XL (DCX)
- Lissencephaly, XL 2 (ARX)
- Mental retardation, AR 34, with variant lissencephaly (CRADD)
- Microcephaly 2, primary, AR, with/-out cortical malformations (WDR62)
- Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 1 (POMT1))
- Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 11 (B3GALNT2)
- Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 13 (B4GAT1)
- Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 14 (GMPPB)
- Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 2 (POMT2)
- Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 3 (POMGNT1)
- Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 4 (FKTP)
- Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 5 (FKRP)
- Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 6 (LARGE1)
- Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 7 (CRPPA)
- Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 8 (POMGNT2)
- Muscular dystrophy-dystroglycanopathy (cong. with mental retardation), type B, 1 (POMT1)
- Muscular dystrophy-dystroglycanopathy (cong. with mental retardation), type B, 14 (GMPPB)
- Muscular dystrophy-dystroglycanopathy (cong. with mental retardation), type B, 2 (POMT2)
- Muscular dystrophy-dystroglycanopathy (cong. with mental retardation), type B, 3 (POMGNT1)
- Muscular dystrophy-dystroglycanopathy (cong. with mental retardation), type B, 6 (LARGE1)
- Muscular dystrophy-dystroglycanopathy (cong. with/-out mental retardation), type B, 5 (FKRP)
- Muscular dystrophy-dystroglycanopathy (cong. without mental retardation), type B, 4 (FKTP)
- Proud syndrome (ARX)
- Subcortical laminal heterotopia, XL (DCX)
- Subcortical laminar heterotopia (PAFAH1B1)
- AD
- AD und/oder AR
- AR
- XL
- Multiple OMIM-Ps
Bioinformatik und klinische Interpretation
Kein Text hinterlegt